• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number U41502H25RX
Medical Device Problem Codes Material Rupture (1546); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/07/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during an angioplasty procedure, the pta balloon allegedly ruptured.It was further reported that the damage was found at the proximal part after removed.There was no reported patient injury.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one ultraverse rx pta dilatation catheter was received in three segments for evaluation.During visual evaluation, segment (1) consisted of the proximal end of the catheter.The catheter was noted to be torn at the guidewire exit port with metal material being exposed.No damage was noted to the inflation hub.Segment (2) consisted of the remaining detached portion of the proximal end of the balloon with partial guidewire exposed.Segment (3) consisted of clear catheter tubing with a tear at the guidewire exit port and partial guidewire present with bunching.Functional testing could not be performed due to the condition of the returned sample.Therefore, the investigation is inconclusive for the reported uncomplicated balloon rupture as no evidence of rupture could be seen.The investigation is confirmed for the identified detachment as the catheter was received detached in three segments.A definitive root cause for the reported uncomplicated balloon rupture and identified detachment could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.(expiry date: 01/2024).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAVERSE RX
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
CLEARSTREAM TECHNOLOGIES LTD.
moyne upper
enniscorthy, co. wexford N A
EI   N A
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key14433262
Report Number2020394-2022-00377
Device Sequence Number5202811
Product Code LIT
UDI-Device Identifier00801741056680
UDI-Public(01)00801741056680
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K131199
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberU41502H25RX
Device Catalogue NumberU41502H25RX
Device Lot NumberCMFP0212
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/26/2022
Initial Report FDA Received Date05/18/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/27/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-